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Introduction 
Apical disease etiopathogenesis
A periapical pathogenic infection exhibits complex microbial 
ecologies. There is a predominance of obligate anaerobic bacteria 
in the necrotic pulp, and a close correlation with black-pigmented 
anaerobic rods in acute periapical inflammation [1]. Many 
endodontopathic black-pigmented species such as P. gingivalis, P. 
nigrescens, and P. intermedia have been observed in extra-radicular 
lesions [2] and strong correlations have been observed with the 
species P. endodontalis, S. sputigena, and Peptostreptococcus 
micros [3]. In contrast, there is negative or no correlation 
with Canocytophaga ochraces, Veillonella parvula and other 
endodontopathic species [3].
Some patients have apical lesions and defective root canal 
treatments which are detected by routine exams or have been 
asymptomatic for years. There have been many varying hypotheses 
on the etiopathogenesis of apical pathosis that include both 
 
bacterial and host factors [2]. It is not clear, however, how a stable 
apical pathosis becomes unstable. For example, how do bacteria 
that have established a permanent residence in necrotic teeth 
and voided root canal fillings with microbial presence become 
unstable? As well, how do asymptomatic teeth with apical lesions 
become unstable?
Besides the various species of bacteria that are pathognomonic 
of acute periapical infections another major factor, the contribution 
of viral infection, should also be considered [4]. In particular, the 
herpesvirus, with its cycle of inactivation and activation may explain 
the episodic nature of periapical disease. Ferreira et al showed 
in two separate studies that exudative samples from acute apical 
abscesses most often contained human herpesvirus-8 (HHV8; 
48% and 54.5% of samples) [5,6]. Guilherme et al found that saliva 
samples from patients with root canals contained HHV-8 in 84% 
of successful root canals, and 89% of failing root canals [7]. The 
Epstein-Barr virus (EBV) was found in 72.5% of apical periodontal 
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Abstract
 There is a need for updating the current treatment modalities for periapical lesions of endodontic origin to reflect the contributions and 
potential morbidity from herpesvirus infection. Herpesviruses, particularly human cytomegalovirus and Epstein-Barr virus, play an important role 
in the symptomatic periapical lesion. Indeed, periapical lesions may remain stable and silent until they become symptomatic, possibly triggered 
by the activation of latent herpesviruses within the lesion itself. Given the potential for grave systemic conditions associated with herpesvirus 
infection, early detection and treatment decisions for periapical lesions by the dentist may positively affect a patient’s overall health; especially for 
the immunocompromised patient.
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lesions in a subpopulation of Hungarians [8]. Additionally, these 
same studies identified the presence of several other herpesviruses 
in some of their samples including varicella zoster virus and human 
cytomegalovirus (HCMV). Jakovljevic et al. reported that EBV EB 
nuclear antigen type I and HCMV glycoprotein B (gB) type 2 are 
the most frequently detected genotypes in apical periodontitis in 
a Serbian population [9]. While in its latent state, the inactive virus 
may correspond to extended periods of dormant periapical disease 
progression, whereas the active virus may be associated with rapid 
periapical tissue breakdown. A vicious cycle between the varying 
bacterial composition of the biofilm in the dentinal tubules or 
accessory canals, along with herpesvirus coinfection, offers a viable 
explanation for the conversion of a stable apical pathosis into an 
unstable state.
The overgrowth of pathogenic microorganisms alongside 
consequent immune impairment and other virulence factors 
make herpesvirus a potent feature in the formation of periapical 
pathosis [1]. The presence of HCMV or EBV is strongly connected 
with increased levels of P. intermedia, A. actinomycetecomitans, T. 
forsythensis and P. gingivalis bacterial species [10]. From a sample 
of 58 teeth with apical periodontitis, 75.9% contained EBV and were 
significantly associated with the presence of the pro-inflammatory 
and osteoclastic mediator tumor necrosis factor-alpha [11]. HCMV 
glycoprotein gB and several surface proteins of EBV, including 
the glycoprotein gp350, latent membrane protein 1, and nuclear 
antigen 2 are implicated in the strong cellular signaling responses 
of the host [12]. Nonappearance of herpesviral factors may be the 
reason for extended periapical lesion dormancy and stability. When 
herpesvirus is not present, or the viral vectors are not reactivated, 
the periapical disease progression is halted. This significant factor 
may hold the key for periapical disease treatment [13].
In immunocompetent and immunocompromised individuals, 
the innate immune response to initial herpesvirus infection is 
activated through recognition of the virus by toll-like receptors 
[14]. As the viral infection enters latency, reactivation of the virus 
is combatted primarily by adaptive immune responses [15]. A 
diminished immune response has been observed in mice co-infected 
with P. gingivalis and cytomegalovirus. This has been attributed to 
a down-regulation of T-cell receptors from bacterial antigens [16]. 
The importance of herpesvirus associations in periapical pathosis 
has been established [17,18]. In addition, a significant link of 
bacterial co-infection with herpesviral vectors and a tendency for 
a more severe and progressive form of the disease has been shown 
[4]. The results of these studies indicate an undefined role of 
herpesvirus factors as another causative agent in the impaired host 
immune response to endodontic infection. Furthermore, the effect 
of bacterial and herpesvirus co-infection in immunocompromised 
individuals warrants further study. This implies a direct need for 
stricter prophylactic treatments for endodontic diseases that 
increase patient compliance and care.
Associated host responses can also explain most of the variations 
in the clinical manifestations of endodontic pathosis [17,18]. 
However, there is not a clear guideline for the recommendation of 
treatment for asymptomatic periapical lesions. Therefore, should 
we consider any tooth presenting with a periapical lesion as a 
diseased tooth? The current endodontic diagnosis rubric does not 
formulate a specific treatment, nor help in the understanding of 
how an unstable lesion becomes symptomatic. In addition, biofilms 
alone cannot explain the progression of the disease. Herpesvirus 
activation by impairment of cell-mediated immunity should be 
included as a potential trigger point for progressive and persistent 
apical disease.
Therefore, this article is aimed to highlight the need for 
an update to current terminology and related therapy for the 
classification and diagnosis of periapical disease of endodontic 
origin based on viral status. In addition to the well-known bacterial 
contribution to periapical disease, many recent studies have shown 
that viruses, particularly herpesviruses, may play an important role. 
Given the potential serious effect herpesviruses have on general 
health, especially in immunocompromised individuals, the dental 
clinician is uniquely situated for both the detection of the virus and 
the prevention of systemic sequelae from herpesvirus infections.
Discussion
Endodontic diagnostics and classification
A big challenge in endodontics is how to approach the apparent 
under-diagnosis of periapical disease. Are any low-density findings 
in a CBCT image associated with the periapical area of a tooth alone 
justification for treatment? Because very early lesions may not 
show any radiographic changes, diagnosis of these lesions relies 
on the clinical symptoms of pulpitis or necrosis, and the method of 
screening for the symptoms.
The current endodontic diagnosis rubric does not help us to 
understand the pathophysiology and timespan of the disease from 
its initiation to the appearance of clinical signs and symptoms. Acute 
apical disease is characterized by swelling and formation of pus, 
while chronic apical disease is the state with sinus tract formations 
[19]. However, these terms contain no information that can guide us 
to a specific etiology to formulate a therapeutic guide. The current 
classification and disease features may help us to understand when 
a disease is stable, but do not provide any information to guide us to 
understand an unstable lesion. Variables such as etiology, disease 
activity and degree of apical tissue destruction should be used in 
formulating a new classification system in order to guide us to 
better treatment options with better healing rates.
Endodontic epidemiology
Periapical pathosis is a compound condition having multiple 
factors, arising from either infection of necrotic pulp, or a failed 
endodontic treatment. It occurs when the bacterial infection 
within the pulp and canal space elicits an inflammatory response 
around the apex of the root. This inflammatory process can also be 
aggravated due to herpesviral vectors.
The prevalence estimates of endodontic lesions depend on 
the case definition of either acute or chronic conditions and the 
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radiographic features of periapical inflammatory lesions, which vary 
depending on the time course of the lesion. It affects a significant 
proportion of people in different populations. Numerous studies 
have shown prevalence estimates for apical periodontitis in root 
filled teeth from many distinct geographical areas. For example, in 
a Danish population of adults 18 years or older 20% of root filled 
teeth had apical periodontitis [20], while 64.5% of root filled teeth 
had apical periodontitis in a Spanish population of adults 18 years 
or older [21]. The range of prevalence of apical periodontitis across 
geographical areas varies widely and is confounded by differing 
ages within each population. Indeed, the studies investigated an 
adult population over 18 years of age, but apical periodontitis 
prevalence (44.3%) in root filled teeth in a Canadian population 
was limited to 25-40-year old [22].
The initial progression of the apical disease process is aided 
by herpesviral infection, although this cannot be detected by 
conventional clinical and radiographic methods [23]. This initial 
infection creates a synergistic relationship with the microbial 
organisms within the biofilm and the initiation of periapical 
infections [24]. Biofilm acids diffuse below the surface and 
demineralize the more soluble subsurface of tooth structure. 
This process leads to lymphocyte and memory B-cell infiltration 
[16]. In addition to the T cell and B-cell infiltrates, macrophages 
also proliferate. The inflammatory process is further aided by 
herpesviral vectors which can cause further inflammation and 
dissolution [12,25].
Severe apical periodontitis is due to specific bacterial species 
and a destructive immune response, which is identical to active 
herpesvirus infections. The body of research suggests a role for 
herpesvirus in the development of periapical pathosis. Herpesvirus 
activation may lead to breakdown of the periodontal tissue and lead 
to severe periapical periodontitis [26]. Furthermore, in cases of 
latency of the herpesvirus, severe apical pathosis may not be seen. 
As CBCT has become more widely used in endodontic diagnosis, 
many asymptomatic periapical lesions have likely gone previously 
undetected [27,28]. These may represent inactive endodontic 
lesions with latent herpesvirus infection. The herpesvirus and the 
microbiota of periapical disease form a commensal relationship 
and may work in conjunction with bacteria responsible for 
severe apical periodontitis and as such, herpesvirus may result 
in the formation of the periapical disease state. A potential causal 
relationship has been shown between EBV and anaerobic bacteria 
in symptomatic apical periodontitis [29]. Therefore, preventing 
herpesvirus activation by using antiviral medication may affect the 
degree of breakdown of the periapical tissue and the development 
of active apical disease. The intersection of genetics, infectious 
disease states, immunology and their role in periapical pathosis can 
be better understood when a clear connection between herpesvirus 
and apical disease is established.
Endodontic lesions occurred with particularly high prevalence 
in low-income and older individuals (30), though the concurrent 
number of people having both apical disease and herpesviral 
infection remains unknown. It has been noted that a high number 
of the population in developing countries may be infected with 
herpesvirus [31], and its role in the etiopathogenesis of apical 
pathosis cannot be ignored. The average worldwide prevalence 
of severe apical disease has been estimated to be markedly high, 
including countries with relatively little emphasis on periapical 
health care [32].
Apical pathosis and systemic disease
There is a possible link between periapical pathosis and systemic 
disease states although yet, no identifiable correlation between 
bacterial causes of apical periodontitis and systemic disease exist. 
Latent HCMV virus reactivation in apical disease poses a higher risk 
by impairment of immune system and susceptibility to diseases 
[33]. Many cancers have been associated with herpes viruses [4]. 
Latent HCMV virus reactivation also poses a higher risk of failure 
of organ transplants in immunocompromised patients [34]. HCMV 
has been linked to bone marrow transplant failures with significant 
mortality. Primary and reactivated HCMV infection is well known to 
become established in immunocompromised hosts, patients with 
AIDS [16]. It appears to be a possibility that the potential source of 
the virus is a latent infection in periapical lesions.
Systemic conditions, including but not limited to diabetes 
mellitus and cardiovascular disease serve as modifying factors 
which limit the survivability of teeth treated endodontically [35]. 
These systemic modifying factors act to disrupt the immune 
response and as a result may activate latent herpesviruses, thus 
affecting the healing ability of the pulp and periapical tissues. 
Systemic disease states influence the creation of apical pathosis 
by their action on healing and the host immune response and 
therefore influence treatment outcomes of apical conditions. 
These systemic factors show correlation, and therefore must be 
included as diagnostic factors in periapical disease. Care must be 
taken, however, when associating systemic disease states with 
apical conditions since the literature does not currently support 
an absolute correlation of systemic disease states to endodontic 
pathosis [36]. If strong correlations between infection by herpes 
virus and apical pathosis can be elucidated, diagnosis and treatment 
protocols would improve leading to effective treatment for both the 
herpesvirus and periodontitis.
Herpesviruses cooperate with pathogenic bacteria in producing 
a variety of medical diseases, including hepatitis, encephalitis, otitis 
media with fever, infectious mononucleosis, Kaposi’s sarcoma, oral 
hairy leukoplakia and dermal abscess, among many others [37-41] 
HCMV and EBV in particular, are two viruses which contribute to 
severe systemic diseases such as atherosclerosis, nasopharyngeal 
carcinoma, Burkitt’s lymphoma, Non-Hodgkin’s lymphoma, among 
others [37-41]. Since herpesvirus is associated with several systemic 
diseases, encouraging primary care practitioners to refer patients 
with herpesvirus for endodontic evaluation will lead to effective 
early diagnosis and possible treatment of periapical disease. 
Additionally, dentists working with physicians for the management 
of immunocompromised patients undergoing any type of organ 
transplant should monitor for any appearance of apical pathosis. 
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The specific factors tied to the multifactorial etiological factors and 
pathogenesis of endodontic lesions will need broadening and/or 
review to consider the inclusion of herpesviruses among the other 
microorganisms and host immune responses.
Furthermore, herpesvirus-mediated immune suppression may 
be particularly destructive in granulomatous tissues because of an 
already compromised host immune response in periapical lesions.
The Struggle between microbes and immunity
Much about the etiopathogenesis of apical pathosis remains 
to be studied. The molecular events preceding disease onset 
and causative factors including the important roles of HCMV 
and EBV in the development of different periapical lesions need 
to be better understood. HCMV has been shown to increase A. 
actinomycetemcomitans adherence to epithelial cells providing 
evidence of the increased role of the virus with periodontitis 
[42]. There is a high probability that the combined presence of 
herpesviruses and endodontopathic bacteria increases the risk 
of a stable apical disease becoming unstable and developing an 
aggressive periapical and pulpal disease [17,18]. The intrinsic 
host impairment of endodontic lesions is likely to increase 
the risk of herpesvirus activation, establishing a vicious cycle. 
Furthermore, HCMV activation may trans-activate EBV. A high level 
of inflammatory cells co-infected with herpesvirus in apical lesions 
may generate favorable conditions for herpesvirus activation due to 
an immunocompromised host response [17,18].
The changing face of endodontics
Among the many causative factors for apical pathosis, 
herpesvirus has emerged as a strong virulent link.
Severe periapical pathosis can be closely linked to herpesviral 
infection through the destructive immune responses that take place 
[17,18] This may hold true in cases where absence of herpesvirus 
leads to an arrested state of apical breakdown. A strong causative 
link or correlation between herpesvirus and apical pathosis 
would set the stage for a new diagnosis method, better treatment 
modalities and efficacy. Such testing protocols would lead to more 
cost-effective treatment modalities by enabling earlier apical 
surgery and treatment, lowering costs in the future for low-income 
families.
A thorough criteria of endodontic lesions including progression 
of disease state, the role of herpesvirus, the onset of disease 
progression, and the delineation between acute and chronic apical 
pathosis is needed.
Through a classification like this, a diagnostic standard will 
be set using the latest research including viral vectors and disease 
progression. A better understanding of the complex interactions 
between herpesviruses, bacteria, other organisms, and host immune 
responses in periapical lesions might potentially lead to novel 
therapeutic approaches such as root canal irrigants with powerful 
antiviral action, antiviral medication, and vaccine development 
to prevent progression from unstable to stable apical pathosis. 
This would be an engaging and new first step in the link between 
herpesvirus and endodontic treatment. This could be further 
expanded by education for patients suffering from herpesvirus 
on their future need for endodontic treatment. By education, the 
overall systemic health of patients can be maintained and separate 
the line, not only between acute and chronic apical pathosis, but 
between medical and dental treatment needs, as well. Such criteria 
could be incorporated into medical and dental curricula, thereby 
increasing educational awareness between medical professionals. 
This would lead to better educational models for patients and 
address therapeutic needs.
Conclusion
Endodontic treatment needs for population-based decisions 
is unclear because of uncertainty over the prevalence of the 
herpesvirus and its impact on endodontic lesions, and the risk 
of disease progression. A one- time clinical assessment of pulp 
vitality and radiographic assessment is not sufficient for basic 
treatment needs. This is due to an unknown percentage of patients 
with herpesvirus infection who, in the absence of screening and 
subsequent treatment, would not experience uncomfortable 
tooth pain or tooth loss during their lifetime. The mechanism for 
a periapical lesion remaining unstable is yet not clear, though the 
latency of herpesviral vectors may play a part. This prompts a need 
for new treatment guidelines not just restricted to the pulp but also 
taking the inflammatory factors of herpesvirus into account. The 
criteria can be further applied to previous diagnosed cases of apical 
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